Trex Medical slumps further in first quarter:
This article was originally published in Clinica
Executive Summary
Trex Medical, the digital X-ray and mammography subsidiary of Thermo Electron which was put up for sale by the parent company two weeks ago, reported an increased loss in the first quarter. Sales were down dramatically on the same quarter in the previous year, from $64.9 million to $43.9 million. Its loss increased from $1.5 million to $6.9 million. A small part of the loss was represented by restructuring costs, although the benefits of a $14 million cost reduction in the quarter were outweighed by the precipitate sales decline.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.